Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects
Michael N. Sack(National Institutes of Health), Javier Traba(National Institutes of Health), Nehal N. Mehta(National Heart Lung and Blood Institute), Allison M. Meadows(University of Cambridge), Rahul Sharma(University of Tsukuba), Komudi Singh(National Institutes of Health), Julian L. Griffin(University of Aberdeen), Rebecca D. Huffstutler, Heather Teague(National Heart Lung and Blood Institute), Haley Goss-Holmes(National Heart Lung and Blood Institute), Jing Wu(Ningbo University), Rong Tian(Nanjing University of Chinese Medicine), Shahin Hassanzadeh(National Heart Lung and Blood Institute)
Cited by 27
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
|Journal of the American Academy of Dermatology|2019|917
Mitochondrial dysfunction in pathophysiology of heart failure
|Journal of Clinical Investigation|2018|909
Psoriasis
|Nature Reviews Disease Primers|2016|893
Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)
|The Journal of Experimental Medicine|2011|854